Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FAMOTIDINE
- A Study to Assess the Effects of Itraconazole, Food, and pH on the Drug Levels of BMS-986368 in Healthy Participants
- Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor
- A Study to Evaluate the Safety, Tolerability, Drug Levels, Food, Formulation, and pH Effects on Relative Absorption of BMS-986465 and Its Active Derivative BMS-986464 in Healthy Participants
- A Study to Investigate the Effects of Acid Reducing Agents on Pharmacokinetics of PC14586 in Healthy Participants
- Multimodal Pain Package vs. Regular Formulation for Pain Management in Ambulatory Spinal Surgery
- Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial
- A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants
- A Study to Evaluate the Impact of Acid-reducing Agents on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants
- A Phase 1 Study to Evaluate the Pharmacokinetics and Safety of MB1707 in Patients With Advanced Cancer
- Gastrointestinal Dysmotility on Aspiration Risk
- Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)
- Interest of Famotidine in Children With Sickle Cell Disease
- Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2)
- LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)
- Combined Antihistaminics Therapy in COVID 19 Patients
- Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)
- A Study to Evaluate the Drug Levels of Deucravacitinib From Tablets After Oral Administration in Healthy Participants
- Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy Participants
- A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants
- A Study to Explore the Effect of Acid-reducing Agents
- Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)
- A Study Evaluating Relative Bioavailability of an Oral Suspension of Abrocitinib and Effect of an Acid Reducing Agent on the Bioavailability of Abrocitinib and Assessing the Taste of Abrocitinib Oral Formulations.
- Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel
- Cetirizine and Famotidine for COVID-19
- Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19
- An Outpatient Study Investigating Non-prescription Treatments for COVID-19
- Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia
- Remotely-conducted Trial of Famotidine vs Placebo for Patients at Home With Coronavirus (COVID) of 2019 (COVID-19)
- A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986337 When Taken by Mouth by Healthy Participants
- Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19
- Impact of a Histamine H2 Receptor Antagonist (H2RA) on the Pharmacokinetics (PK) of Telaglenastat in Healthy Subjects
- A Study to Evaluate the Drug Levels of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants
- Role of Famotidine in the Clinical Improvement of COVID-19 Patients.
- Study to Assess the Effect of Acid-reducing Agent Famotidine on the Drug Levels of BMS-986256 in Healthy Participants
- A Study to Assess the Effects of Acid-Reducing Agent(s) on JNJ-64417184 in Healthy Participants
- Histamine H1/H2 Receptors and Training Adaptations
- A Study in Healthy Male Subjects to Investigate the Effect of Famotidine and Efavirenz on the Way the Body Takes up, Distributes, and Gets Rid of Daridorexant.
- Multi-site Adaptive Trials for COVID-19
- A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation
- Antihistamines in Eosinophilic Esophagitis
- A Study Comparing the Effects of Famotidine Pretreatment and of Food on the Relative Bioavailability of BMS-986165 in Healthy Volunteers
- A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With Famotidine
- A Study Assessing the Drug Levels, Drug Effects, and Safety of BMS-986322 in Healthy Participants
- BE Study of Gaster®D Tab 20mg (Manufacturer Changed)
- A Study to Determine the Pharmacokinetic Profile of BMS-986165 Tablets
- Title: Moxetumomab Pasudotox-tdfk (Lumoxiti ) and Rituximab (Rituxan ) for Relapsed Hairy Cell Leukemia
- Comparison of TAP, Anterior QL, or ESP Block for Elective Cesarean Section
- Stress Ulcer Prophylaxis Versus Placebo in Critically Ill Infants With Congenital Heart Disease
- Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension
- Study to Assess the Pharmacokinetic Drug-Drug Interactions of Lemborexant When Coadministered With an Oral Contraceptive, Famotidine, or Fluconazole in Healthy Subjects
- Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology
- A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity
- A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986263 in Healthy Participants
- Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer
- A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects
- Ilaris (Canakinumab) in Patient With Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA)
- Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis
- Prophylaxis for Aspiration of Gastric Contents.
- In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms?
- Pharmacokinetic and Safety Study of Cenicriviroc and Acid Reducing Agents When Dosed Alone or in Combination
- Proton Pump Inhibitors and Risk of Community-acquired Pneumonia
- Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers
- Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis
- The Effect of BIS Monitorization to Intraoperative Anesthetic Consumption During Coronary Artery Surgery
- Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV)
- Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer
- Anesthetics in Rhytidoplasty - A Comparison Study
- Histamine Glutamate Antagonism in Stroke
- Safety Study of TPI-287 to Treat CBS and PSP
- Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)
- Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food
- Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment
- Famotidine in Schizophrenia
- Famotidine for Levodopa-induced Dyskinesia in PD
- Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn Episodes
- Bioequivalence Study of FLURBIPROFEN 100 mg FAMOTIDINE 20 mg MULTI-LAYER TABLET in Healthy Subjects Under Fasting Conditions
- Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
- Bioavailability Study of Famotidine Tablets 40 mg Under Fasting Conditions
- A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients
- ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASA
- Open-Label Study of TPI 287 for Patients With Metastatic Melanoma
- Trial of Daily Pulse Interleukin-2 With Famotidine in Acute Myelogenous Leukemia
- Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV Infection
- PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers
- A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition
- A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition
- Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer
- A Phase I Study of TPI 287 - Temozolomide Combination in Melanoma
- Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With Aspirin
- A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054)
- Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
- Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer Dyspepsia
- Platelet Inhibitory Effect of Clopidogrel in Patients Treated With Omeprazole, Pantoprazole, or Famotidine
- A Study to Assess the Bioequivalence of Famotidine Chewable Tablets and Film-Coated Tablets (0208-144)
- A Study to Assess the Bioequivalence of Famotidine/Antacid Combination Tablets Compared to Famotidine/Antacid EZ Chew Tablets (0208C-145)(COMPLETED)
- Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion
- Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer Prophylaxis
- Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed Conditions
- Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fasting Conditions
- Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart Disease
- Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care Unit
- Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
- Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216)
- Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant Schizophrenia
- Ulcer Prevention Study in Post Gastric Bypass Patients
- Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery
- Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer
- Study of XL281 in Adults With Solid Tumors
- Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers
- Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment
- A Phase I Study of Oral Ixabepilone in Subjects With Advanced Cancer
- Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients
- Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir
- Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -
- Effect of Selective COX-2 Inhibition on Ulcer Healing
- Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease
Clinical trials list
click for details